Dr Roger T Pelli, DO | |
140 Academy St, Presque Isle, ME 04769-3102 | |
(207) 768-4000 | |
(207) 768-4046 |
Full Name | Dr Roger T Pelli |
---|---|
Gender | Male |
Speciality | Hospitalist |
Location | 140 Academy St, Presque Isle, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073539581 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 1213 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Roger T Pelli, DO 140 Academy St, Presque Isle, ME 04769-3102 Ph: (207) 768-4000 | Dr Roger T Pelli, DO 140 Academy St, Presque Isle, ME 04769-3102 Ph: (207) 768-4000 |
News Archive
Allos Therapeutics, Inc. today announced that the Company has reached agreement with the U.S. Food and Drug Administration (FDA) under its Special Protocol Assessment (SPA) process for the design of the Company's Phase 3 clinical trial of FOLOTYN® (pralatrexate injection) in patients with previously undiagnosed peripheral T-cell lymphoma (PTCL).
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
A Johns Hopkins review of more than 38,000 patient records finds that older adults who sustain substantial head trauma over a weekend are significantly more likely to die from their injuries than those similarly hurt and hospitalized Monday through Friday, even if their injuries are less severe and they have fewer other illnesses than their weekday counterparts.
Providing a method to precisely move microscopes while allowing the sample to remain stationary, the new ZDP50K Translation Stage from Prior Scientific is compatible with all modern research microscopes.
Methicillin-resistant Staphylococcus aureus (MRSA) is a major problem in nursing homes with one in four residents carrying the bacteria, a study by Queen's University Belfast and Antrim Area Hospital has found.
› Verified 3 days ago
Dr. Ram Mohan Rao Venepally, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4412 | |
Dr. Lora J Jobe, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000 Fax: 207-768-4046 | |
Saad Ali, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 585-922-4000 | |
Dr. Mohammed S Aziz, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000 Fax: 207-768-4046 | |
Dr. Niraj Karki, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000 |